Who invested in Allecra Therapeutics?
Allecra Therapeutics's investors include Forbion Capital Partners, Edmond de Rothschild Venture Capital, EMBL Ventures and Delos Capital.
France · Series B startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$44Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finance.yahoo.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Allecra Therapeutics's investors include Forbion Capital Partners, Edmond de Rothschild Venture Capital, EMBL Ventures and Delos Capital.
Allecra Therapeutics has raised $44M across 2 rounds since 2013.
Allecra Therapeutics's most recent round was a Series B of $24M in Jun 2016.
Its most recent round, $24M in Jun 2016, is also its largest on record.
Allecra Therapeutics's first round on record, in Apr 2013, was backed by Forbion Capital Partners, Edmond de Rothschild Venture Capital and EMBL Ventures.
Allecra Therapeutics's latest named round is a Series B, in Jun 2016.
Allecra Therapeutics is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.